Mario Thevis
#149,506
Most Influential Person Now
Researcher
Mario Thevis's AcademicInfluence.com Rankings
Mario Thevisphilosophy Degrees
Philosophy
#8207
World Rank
#11542
Historical Rank
Logic
#5237
World Rank
#6621
Historical Rank

Download Badge
Philosophy
Mario Thevis's Degrees
- PhD Sports Science University of Cologne
- Masters Sports Science University of Cologne
- Bachelors Sports Science University of Cologne
Why Is Mario Thevis Influential?
(Suggest an Edit or Addition)Mario Thevis's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Nutritional supplements cross-contaminated and faked with doping substances. (2008) (328)
- Factors influencing the steroid profile in doping control analysis. (2008) (229)
- Δ6‐Desaturase (FADS2) deficiency unveils the role of ω3‐ and ω6‐polyunsaturated fatty acids (2008) (199)
- Mass spectrometry in sports drug testing: Structure characterization and analytical assays. (2007) (168)
- Determination of 13C/12C ratios of endogenous urinary steroids: method validation, reference population and application to doping control purposes. (2008) (154)
- RBC-NOS-Dependent S-Nitrosylation of Cytoskeletal Proteins Improves RBC Deformability (2013) (143)
- In vitro phase I metabolism of the synthetic cannabimimetic JWH-018 (2010) (142)
- Sensitive determination of prohibited drugs in dried blood spots (DBS) for doping controls by means of a benchtop quadrupole/Orbitrap mass spectrometer (2012) (132)
- Screening for the synthetic cannabinoid JWH-018 and its major metabolites in human doping controls. (2011) (129)
- Screening for unknown synthetic steroids in human urine by liquid chromatography-tandem mass spectrometry. (2005) (129)
- Mass spectrometric identification and characterization of a new long-term metabolite of metandienone in human urine. (2006) (113)
- Quantification of human insulin-like growth factor-1 and qualitative detection of its analogues in plasma using liquid chromatography/electrospray ionisation tandem mass spectrometry. (2008) (102)
- Glucuronidation of anabolic androgenic steroids by recombinant human UDP-glucuronosyltransferases. (2003) (99)
- Qualitative determination of synthetic analogues of insulin in human plasma by immunoaffinity purification and liquid chromatography-tandem mass spectrometry for doping control purposes. (2005) (99)
- Current role of LC-MS(/MS) in doping control (2007) (97)
- Mass spectrometric determination of insulins and their degradation products in sports drug testing. (2008) (96)
- Confiscated black market products and nutritional supplements with non-approved ingredients analyzed in the Cologne Doping Control Laboratory 2009. (2010) (95)
- Discrimination of recombinant and endogenous urinary erythropoietin by calculating relative mobility values from SDS gels. (2008) (92)
- Anabolic agents: recent strategies for their detection and protection from inadvertent doping (2014) (90)
- Liquid chromatography/electrospray ionization tandem mass spectrometric screening and confirmation methods for beta2-agonists in human or equine urine. (2003) (89)
- Doping control analysis of intact rapid-acting insulin analogues in human urine by liquid chromatography-tandem mass spectrometry. (2006) (88)
- Immunoaffinity purification of peptide hormones prior to liquid chromatography-mass spectrometry in doping controls. (2012) (83)
- Obesity resistance of the stearoyl-CoA desaturase-deficient (scd1 -/-) mouse results from disruption of the epidermal lipid barrier and adaptive thermoregulation (2007) (83)
- Determination of growth hormone releasing peptides (GHRP) and their major metabolites in human urine for doping controls by means of liquid chromatography mass spectrometry (2011) (82)
- Interlaboratory agreement of insulin-like growth factor 1 concentrations measured by mass spectrometry. (2014) (79)
- Aryl-Propionamide-Derived Selective Androgen Receptor Modulators: Liquid Chromatography-Tandem Mass Spectrometry Characterization of the in Vitro Synthesized Metabolites for Doping Control Purposes (2008) (77)
- Screening for metabolically stable aryl-propionamide-derived selective androgen receptor modulators for doping control purposes. (2006) (77)
- Hypoxia-inducible factor stabilizers and other small-molecule erythropoiesis-stimulating agents in current and preventive doping analysis. (2012) (76)
- Sports drug testing using complementary matrices: Advantages and limitations. (2016) (74)
- Sensitive and fast identification of urinary human, synthetic and animal insulin by means of nano-UPLC coupled with high-resolution/high-accuracy mass spectrometry. (2009) (74)
- Identification of black market products and potential doping agents in Germany 2010–2013 (2014) (73)
- Mass spectrometric identification of degradation products of insulin and its long-acting analogues in human urine for doping control purposes. (2007) (73)
- Characterization of chemically modified steroids for doping control purposes by electrospray ionization tandem mass spectrometry. (2005) (72)
- High-throughput screening for various classes of doping agents using a new 'dilute-and-shoot' liquid chromatography-tandem mass spectrometry multi-target approach. (2011) (71)
- Structure characterisation of urinary metabolites of the cannabimimetic JWH-018 using chemically synthesised reference material for the support of LC-MS/MS-based drug testing (2011) (69)
- Mass spectrometry of stanozolol and its analogues using electrospray ionization and collision-induced dissociation with quadrupole-linear ion trap and linear ion trap-orbitrap hybrid mass analyzers. (2005) (68)
- Simultaneous determination and validated quantification of human insulin and its synthetic analogues in human blood serum by immunoaffinity purification and liquid chromatography-mass spectrometry (2012) (67)
- Different mechanical loading protocols influence serum cartilage oligomeric matrix protein levels in young healthy humans (2010) (66)
- Development and validation of a mass spectrometric detection method of peginesatide in dried blood spots for sports drug testing (2012) (63)
- Mass spectrometric determination of gonadotrophin-releasing hormone (GnRH) in human urine for doping control purposes by means of LC-ESI-MS/MS. (2008) (63)
- Analysis of confiscated black market drugs using chromatographic and mass spectrometric approaches. (2008) (63)
- High speed determination of beta-receptor blocking agents in human urine by liquid chromatography/tandem mass spectrometry. (2001) (62)
- Obesity resistance and deregulation of lipogenesis in Δ6‐fatty acid desaturase (FADS2) deficiency (2014) (61)
- Clenbuterol - regional food contamination a possible source for inadvertent doping in sports. (2012) (61)
- Evaluation of commercially available assays for the measurement of equine insulin. (2011) (61)
- New potential markers for the detection of boldenone misuse (2012) (60)
- Expanding analytical possibilities concerning the detection of stanozolol misuse by means of high resolution/high accuracy mass spectrometric detection of stanozolol glucuronides in human sports drug testing. (2013) (59)
- Determination of prohibited, small peptides in urine for sports drug testing by means of nano-liquid chromatography/benchtop quadrupole orbitrap tandem-mass spectrometry. (2012) (59)
- Anabolic, doping, and lifestyle drugs, and selected metabolites in wastewater—detection, quantification, and behaviour monitored by high-resolution MS and MSn before and after sewage treatment (2010) (58)
- Identification of the growth-hormone-releasing peptide-2 (GHRP-2) in a nutritional supplement. (2010) (58)
- Comprehensive plasma-screening for known and unknown substances in doping controls. (2010) (58)
- Gender differences in the bronchoalveolar lavage cell proteome of patients with chronic obstructive pulmonary disease. (2013) (57)
- Detection of the arylpropionamide-derived selective androgen receptor modulator (SARM) S-4 (Andarine) in a black-market product. (2009) (57)
- Examples of doping control analysis by liquid chromatography-tandem mass spectrometry: ephedrines, beta-receptor blocking agents, diuretics, sympathomimetics, and cross-linked hemoglobins. (2005) (57)
- Urinary concentrations of morphine and codeine after consumption of poppy seeds. (2003) (56)
- Mass spectrometry of selective androgen receptor modulators. (2008) (55)
- Emerging drugs: mechanism of action, mass spectrometry and doping control analysis. (2009) (55)
- Determination of the origin of urinary norandrosterone traces by gas chromatography combustion isotope ratio mass spectrometry. (2006) (55)
- Determination of IGF-1 and IGF-2, their degradation products and synthetic analogues in urine by LC-MS/MS. (2011) (53)
- Synthesis, characterization, and detection of new oxandrolone metabolites as long-term markers in sports drug testing (2013) (52)
- Liquid chromatographic-mass spectrometric analysis of glucuronide-conjugated anabolic steroid metabolites: method validation and interlaboratory comparison. (2008) (52)
- Determination of human insulin and its analogues in human blood using liquid chromatography coupled to ion mobility mass spectrometry (LC-IM-MS). (2014) (52)
- Mass Spectrometry in Sports Drug Testing: Characterization of Prohibited Substances and Doping Control Analytical Assays (2010) (51)
- Determination of Vasopressin and Desmopressin in urine by means of liquid chromatography coupled to quadrupole time-of-flight mass spectrometry for doping control purposes. (2011) (49)
- Long‐term engraftment following transplantation of pig pancreatic primordia into non‐immunosuppressed diabetic rhesus macaques (2007) (48)
- Annual banned-substance review: analytical approaches in human sports drug testing. (2012) (48)
- Detection of SARMs in doping control analysis (2017) (47)
- Use of dried blood spots in doping control analysis of anabolic steroid esters. (2014) (47)
- Proteases in doping control analysis. (2007) (47)
- Determination of (13)C/(12)C ratios of endogenous urinary steroids excreted as sulpho conjugates. (2010) (46)
- Application of FAIMS to anabolic androgenic steroids in sport drug testing. (2009) (46)
- Enzyme-assisted synthesis and structure characterization of glucuronide conjugates of eleven anabolic steroid metabolites (2008) (46)
- Identification of the aromatase inhibitors anastrozole and exemestane in human urine using liquid chromatography/tandem mass spectrometry. (2006) (46)
- Analytical approaches for the detection of emerging therapeutics and non-approved drugs in human doping controls. (2014) (46)
- Measuring insulin in human vitreous humour using LC-MS/MS. (2012) (45)
- Mass spectrometric analysis of androstan-17β-ol-3-one and androstadiene-17β-ol-3-one isomers (2005) (44)
- Screening for 2-quinolinone-derived selective androgen receptor agonists in doping control analysis. (2007) (44)
- Metabolism of growth hormone releasing peptides. (2012) (44)
- Identification of Fentanyl, Alfentanil, Sufentanil, Remifentanil and Their Major Metabolites in Human Urine by Liquid Chromatography/Tandem Mass Spectrometry for Doping Control Purposes (2005) (44)
- Plasticizers excreted in urine: indication of autologous blood transfusion in sports (2012) (43)
- Does the analysis of the enantiomeric composition of clenbuterol in human urine enable the differentiation of illicit clenbuterol administration from food contamination in sports drug testing? (2013) (43)
- Characterisation of the pharmacological profile of desoxymethyltestosterone (Madol), a steroid misused for doping. (2007) (43)
- Mass spectrometric characterization of urinary metabolites of the selective androgen receptor modulator andarine (S-4) for routine doping control purposes. (2010) (42)
- Dietary Supplement and Food Contaminations and Their Implications for Doping Controls (2020) (42)
- Detection of the plasma volume expander hydroxyethyl starch in human urine. (2000) (42)
- Traditional Chinese medicine and sports drug testing: identification of natural steroid administration in doping control urine samples resulting from musk (pod) extracts (2012) (41)
- Exercise and the Kynurenine pathway: Current state of knowledge and results from a randomized cross-over study comparing acute effects of endurance and resistance training. (2020) (41)
- “Dilute-and-inject” multi-target screening assay for highly polar doping agents using hydrophilic interaction liquid chromatography high resolution/high accuracy mass spectrometry for sports drug testing (2015) (41)
- Mildronate (Meldonium) in professional sports – monitoring doping control urine samples using hydrophilic interaction liquid chromatography – high resolution/high accuracy mass spectrometry (2015) (41)
- Doping control analysis of selected peptide hormones using LC-MS(/MS). (2011) (41)
- Detection of manipulation in doping control urine sample collection: a multidisciplinary approach to determine identical urine samples (2007) (41)
- Ultrahigh pressure liquid chromatography-(tandem) mass spectrometry in human sports drug testing: possibilities and limitations. (2013) (41)
- New drugs and methods of doping and manipulation. (2008) (40)
- Determination of Synacthen in human plasma using immunoaffinity purification and liquid chromatography/tandem mass spectrometry. (2006) (40)
- Dried blood spots (DBS) for doping control analysis (2011) (40)
- Unusual mass spectrometric dissociation pathway of protonated isoquinoline-3-carboxamides due to multiple reversible water adduct formation in the gas phase (2009) (40)
- Doping-Control Analysis of the 5α-Reductase Inhibitor Finasteride: Determination of Its Influence on Urinary Steroid Profiles and Detection of Its Major Urinary Metabolite (2007) (40)
- Identification of human pituitary growth hormone variants by mass spectrometry. (2009) (40)
- Determination of benzimidazole- and bicyclic hydantoin-derived selective androgen receptor antagonists and agonists in human urine using LC–MS/MS (2008) (40)
- Annual banned-substance review: analytical approaches in human sports drug testing. (2010) (40)
- Simplifying and expanding analytical capabilities for various classes of doping agents by means of direct urine injection high performance liquid chromatography high resolution/high accuracy mass spectrometry. (2016) (40)
- Mass spectrometric characterization of urinary metabolites of the selective androgen receptor modulator S-22 to identify potential targets for routine doping controls. (2011) (39)
- Adverse analytical findings with clenbuterol among U-17 soccer players attributed to food contamination issues. (2013) (38)
- Characterization of two major urinary metabolites of the PPARδ-agonist GW1516 and implementation of the drug in routine doping controls (2010) (38)
- Trafficking of drug candidates relevant for sports drug testing: detection of non-approved therapeutics categorized as anabolic and gene doping agents in products distributed via the Internet. (2011) (38)
- Identification of the aromatase inhibitor letrozole in urine by gas chromatography/mass spectrometry. (2005) (37)
- Detection of Surreptitious Administration of Analog Insulin to an 8-Week-Old Infant (2010) (37)
- Rapid determination of urinary di(2-ethylhexyl) phthalate metabolites based on liquid chromatography/tandem mass spectrometry as a marker for blood transfusion in sports drug testing (2011) (37)
- Quantification of urinary AICAR concentrations as a matter of doping controls (2010) (37)
- Sports drug testing: Analytical aspects of selected cases of suspected, purported, and proven urine manipulation. (2012) (36)
- Determination of Synacthen in urine for sports drug testing by means of nano-ultra-performance liquid chromatography/tandem mass spectrometry. (2009) (36)
- Emerging drugs--potential for misuse in sport and doping control detection strategies. (2007) (36)
- Fully automated determination of nicotine and its major metabolites in whole blood by means of a DBS online-SPE LC-HR-MS/MS approach for sports drug testing. (2016) (36)
- Investigations of the microbial transformation of cortisol to prednisolone in urine samples (2012) (36)
- Metabolism of 4-hydroxyandrostenedione and 4-hydroxytestosterone: Mass spectrometric identification of urinary metabolites (2007) (35)
- Characterization of in vitro generated metabolites of the selective androgen receptor modulators S-22 and S-23 and in vivo comparison to post-administration canine urine specimens. (2010) (35)
- Detection of homologous blood transfusion. (2007) (35)
- Stimulants and doping in sport. (2010) (34)
- Determination of the prevalence of anabolic steroids, stimulants, and selected drugs subject to doping controls among elite sport students using analytical chemistry (2008) (34)
- Recommended criteria for the mass spectrometric identification of target peptides and proteins (<8 kDa) in sports drug testing. (2007) (34)
- Synthetic anabolic agents: steroids and nonsteroidal selective androgen receptor modulators. (2010) (34)
- Analytical challenges in the detection of peptide hormones for anti-doping purposes. (2012) (34)
- SERMs and SARMs: Detection of their activities with yeast based bioassays (2010) (34)
- Determination of 74 new psychoactive substances in serum using automated in-line solid-phase extraction-liquid chromatography-tandem mass spectrometry. (2017) (34)
- Determination of N-Desmethyl- and N-Bisdesmethyl Metabolites of Sibutramine in Doping Control Analysis Using Liquid Chromatography-Tandem Mass Spectrometry (2006) (34)
- Quantification of Clenbuterol in Human Plasma and Urine by Liquid Chromatography-Tandem Mass Spectrometry (2005) (34)
- Synthesis, characterisation, and mass spectrometric detection of a pegylated EPO-mimetic peptide for sports drug testing purposes. (2011) (34)
- Simplifying and expanding the screening for peptides <2 kDa by direct urine injection, liquid chromatography, and ion mobility mass spectrometry. (2016) (33)
- Can dried blood spots (DBS) contribute to conducting comprehensive SARS‐CoV‐2 antibody tests? (2020) (33)
- Mass spectrometric characterization of transferrins and their fragments derived by reduction of disulfide bonds (2003) (33)
- Quantitative Analysis of Urinary Glycerol Levels for Doping Control Purposes Using Gas Chromatography-Mass Spectrometry (2008) (32)
- Hydroxyurea therapy modulates sickle cell anemia red blood cell physiology: Impact on RBC deformability, oxidative stress, nitrite levels and nitric oxide synthase signalling pathway. (2018) (32)
- Doping control analysis of tricyclic tetrahydroquinoline-derived selective androgen receptor modulators using liquid chromatography/electrospray ionization tandem mass spectrometry. (2008) (32)
- Determination of growth hormone releasing peptides metabolites in human urine after nasal administration of GHRP-1, GHRP-2, GHRP-6, Hexarelin, and Ipamorelin. (2015) (32)
- Temporal indication of cannabis use by means of THC glucuronide determination. (2009) (31)
- Doping control analysis of emerging drugs in human plasma - identification of GW501516, S-107, JTV-519, and S-40503. (2009) (31)
- Detection of His-tagged Long-R³-IGF-I in a black market product. (2010) (31)
- Doping control analysis of trenbolone and related compounds using liquid chromatography–tandem mass spectrometry (2009) (31)
- Doping control analysis of bovine hemoglobin-based oxygen therapeutics in human plasma by LC-electrospray ionization-MS/MS. (2003) (31)
- Time for change: a roadmap to guide the implementation of the World Anti-Doping Code 2015 (2014) (31)
- Insulins in equine urine: qualitative analysis by immunoaffinity purification and liquid chromatography/tandem mass spectrometry for doping control purposes in horse-racing. (2008) (30)
- Analyses of Meldonium (Mildronate) from Blood, Dried Blood Spots (DBS), and Urine Suggest Drug Incorporation into Erythrocytes (2016) (30)
- Annual banned-substance review: Analytical approaches in human sports drug testing. (2018) (30)
- Detection of Stanozolol and Its Major Metabolites in Human Urine by Liquid Chromatography-Tandem Mass Spectrometry (2006) (30)
- Post-mortem vitreous humour as potential specimen for detection of insulin analogues by LC-MS/MS. (2013) (30)
- Determination of salbutamol and salbutamol glucuronide in human urine by means of liquid chromatography-tandem mass spectrometry. (2011) (30)
- Epiandrosterone sulfate prolongs the detectability of testosterone, 4-androstenedione, and dihydrotestosterone misuse by means of carbon isotope ratio mass spectrometry. (2017) (29)
- Investigation of the in vitro metabolism of the emerging drug candidate S107 for doping-preventive purposes. (2011) (29)
- Induction of micronuclei in V79 cells by the anabolic doping steroids tetrahydrogestrinone and trenbolone (2008) (29)
- Emerging drugs affecting skeletal muscle function and mitochondrial biogenesis - Potential implications for sports drug testing programs. (2016) (29)
- Reporting and managing elevated testosterone/epitestosterone ratios--novel aspects after five years' experience. (2010) (29)
- Human sports drug testing by mass spectrometry. (2017) (29)
- Combination of carbon isotope ratio with hydrogen isotope ratio determinations in sports drug testing (2013) (29)
- Mass spectrometry of hydantoin-derived selective androgen receptor modulators. (2008) (29)
- Genotype-dependent metabolism of exogenous testosterone - new biomarkers result in prolonged detectability. (2016) (28)
- Identification of steroid isoxazole isomers marketed as designer supplement (2009) (28)
- Investigations on hydrogen isotope ratios of endogenous urinary steroids: reference-population-based thresholds and proof-of-concept. (2012) (28)
- 17beta-hydroxy-5alpha-androst-1-en-3-one (1-testosterone) is a potent androgen with anabolic properties. (2006) (28)
- Tetrahydrogestrinone is a potent but unselective binding steroid and affects glucocorticoid signalling in the liver. (2006) (28)
- Mass spectrometric identification of peptide hormones in doping-control analysis. (2007) (28)
- Use of an Electrochemically Synthesised Metabolite of a Selective Androgen Receptor Modulator for Mass Spectrometry-Based Sports Drug Testing (2008) (27)
- Detection of testosterone esters in blood. (2015) (27)
- In-gel derivatization of proteins for cysteine-specific cleavages and their analysis by mass spectrometry. (2003) (27)
- Determination of the deuterium/hydrogen ratio of endogenous urinary steroids for doping control purposes. (2009) (27)
- Screening for Two Selective Androgen Receptor Modulators Using Gas Chromatography-Mass Spectrometry in Doping Control Analysis (2008) (27)
- Fully automated dried blood spot sample preparation enables the detection of lower molecular mass peptide and non-peptide doping agents by means of LC-HRMS (2020) (27)
- Detection of Dehydroepiandrosterone Misuse by Means of Gas Chromatography-Combustion-Isotope Ratio Mass Spectrometry (2007) (27)
- Annual banned-substance review: analytical approaches in human sports drug testing. (2011) (27)
- Characterization of a non-approved selective androgen receptor modulator drug candidate sold via the Internet and identification of in vitro generated phase-I metabolites for human sports drug testing. (2015) (27)
- Gas phase reaction of substituted isoquinolines to carboxylic acids in ion trap and triple quadrupole mass spectrometers after electrospray ionization and collision-induced dissociation (2008) (26)
- Characterization of equine urinary metabolites of selective androgen receptor modulators (SARMs) S1, S4 and S22 for doping control purposes. (2015) (26)
- Rapid screening of polysaccharide-based plasma volume expanders dextran and hydroxyethyl starch in human urine by liquid chromatography-tandem mass spectrometry. (2008) (26)
- Mass spectrometry of steroid glucuronide conjugates. I. Electron impact fragmentation of 5alpha-/5beta-androstan-3alpha-ol-17-one glucuronides, 5alpha-estran-3alpha-ol-17-one glucuronide and deuterium-labelled analogues. (2001) (26)
- Expanded test method for peptides >2 kDa employing immunoaffinity purification and LC-HRMS/MS. (2015) (26)
- Current role of LC–MS(/MS) in doping control (2007) (26)
- Effects of endurance exercise on the urinary proteome analyzed by 2‐D PAGE and Orbitrap MS (2010) (25)
- Identification and quantification of the plasma volume expander dextran in human urine by liquid chromatography-tandem mass spectrometry of enzymatically derived isomaltose. (2005) (25)
- Quantifying cobalt in doping control urine samples--a pilot study. (2014) (25)
- Electrospray ionization mass spectrometric characterization and quantitation of xanthine derivatives using isotopically labelled analogues: an application for equine doping control analysis. (2004) (25)
- Zeranol: doping offence or mycotoxin? A case-related study. (2011) (25)
- Selective androgen receptor modulators: in vitro and in vivo metabolism and analysis (2013) (25)
- Nutrition Status of Young Elite Female German Football Players. (2017) (25)
- Analysis of selective androgen receptor modulators by gas chromatography-microchip atmospheric pressure photoionization-mass spectrometry (2010) (24)
- Qualitative identification of growth hormone-releasing hormones in human plasma by means of immunoaffinity purification and LC-HRMS/MS (2016) (24)
- Development of liquid chromatography-tandem mass spectrometry-based analytical assays for the determination of HIF stabilizers in preventive doping research. (2011) (24)
- Screening of In Vitro Synthesised Metabolites of 4,9,11-Trien-3-One Steroids by Liquid Chromatography-Mass Spectrometry (2008) (24)
- Mass spectrometric behavior of thiazide-based diuretics after electrospray ionization and collision-induced dissociation. (2002) (24)
- Death after misuse of anabolic substances (clenbuterol, stanozolol and metandienone). (2019) (24)
- Hydrogen isotope ratio mass spectrometry and high-resolution/high-accuracy mass spectrometry in metabolite identification studies: detecting target compounds for sports drug testing. (2013) (24)
- Analysis of insulin and insulin analogs from dried blood spots by means of liquid chromatography-high resolution mass spectrometry. (2018) (24)
- Metabolism of Oral Turinabol by Human Steroid Hormone–Synthesizing Cytochrome P450 Enzymes (2016) (24)
- Proteolysis and autolysis of proteases and the detection of degradation products in doping control. (2009) (24)
- Analytical Approaches in Human Sports Drug Testing - Recent Advances, Challenges, and Solutions. (2020) (23)
- Qualitative and Semiquantitative Analysis of Doping Products Seized at the Swiss Border (2017) (23)
- Determination of therapeutics with growth-hormone secretagogue activity in human urine for doping control purposes. (2006) (23)
- Recent instrumental progress in mass spectrometry: advancing resolution, accuracy, and speed of drug detection. (2012) (23)
- Measuring xenon in human plasma and blood by gas chromatography/mass spectrometry. (2014) (23)
- Expanding analytical options in sports drug testing: Mass spectrometric detection of prohibited substances in exhaled breath (2017) (23)
- Detection of the diuretic hydrochlorothiazide in a doping control urine sample as the result of a non-steroidal anti-inflammatory drug (NSAID) tablet contamination. (2016) (23)
- Detection of EPO-Fc fusion protein in human blood: screening and confirmation protocols for sports drug testing. (2012) (22)
- Validated hemoglobin‐depletion approach for red blood cell lysate proteome analysis by means of 2D PAGE and Orbitrap MS (2012) (22)
- Determination of Synacthen® in dried blood spots for doping control analysis using liquid chromatography tandem mass spectrometry (2015) (22)
- Detecting peptidic drugs, drug candidates and analogs in sports doping: current status and future directions (2014) (22)
- Quantification of intact human insulin-like growth factor-I in serum by nano-ultrahigh-performance liquid chromatography/tandem mass spectrometry. (2014) (22)
- Pharmacokinetics of altrenogest in horses. (2007) (21)
- Quantitative Determination of Adrenaline and Noradrenaline in Urine Using Liquid Chromatography-Tandem Mass Spectrometry (2006) (21)
- Dietary ω3-and ω6-Polyunsaturated fatty acids reconstitute fertility of Juvenile and adult Fads2-Deficient mice (2020) (21)
- Determination of ¹³C/¹² C ratios of endogenous urinary 5-amino-imidazole-4-carboxamide 1β-D-ribofuranoside (AICAR). (2014) (21)
- Metabolism of human insulin after subcutaneous administration: A possible means to uncover insulin misuse. (2015) (21)
- Targeting prohibited substances in doping control blood samples by means of chromatographic–mass spectrometric methods (2013) (21)
- Annual banned-substance review: analytical approaches in human sports drug testing. (2016) (21)
- Identification of oral antidiabetics and their metabolites in human urine by liquid chromatography/tandem mass spectrometry--a matter for doping control analysis. (2005) (21)
- Structure Elucidation of the Diagnostic Product Ion at m/z 97 Derived from Androst-4-en-3-One-Based Steroids by ESI-CID and IRMPD Spectroscopy (2012) (21)
- Quantification of AICAR-ribotide concentrations in red blood cells by means of LC-MS/MS (2013) (20)
- Determination of stimulants using gas chromatography/high-resolution time-of-flight mass spectrometry and a soft ionization source. (2012) (20)
- Erythropoietic effects of low-dose cobalt application. (2018) (20)
- Simplified quantification of insulin, its synthetic analogues and C-peptide in human plasma by means of LC-HRMS. (2020) (20)
- Do dried blood spots (DBS) have the potential to support result management processes in routine sports drug testing? (2020) (20)
- Determination of Selected Stimulants in Urine for Sports Drug Analysis by Solid Phase Extraction via Cation Exchange and Means of Liquid Chromatography-Tandem Mass Spectrometry (2008) (20)
- The fungus Cunninghamella elegans can produce human and equine metabolites of selective androgen receptor modulators (SARMs) (2013) (20)
- Mass spectrometry of partially methylated alditol acetates derived from hydroxyethyl starch. (2000) (20)
- Mass spectrometric detection of siRNA in plasma samples for doping control purposes (2010) (20)
- Comparison of the urinary protein patterns of athletes by 2D-gel electrophoresis and mass spectrometry-a pilot study. (2009) (20)
- Storage‐induced changes of the cytosolic red blood cell proteome analyzed by 2D DIGE and high‐resolution/high‐accuracy MS (2012) (19)
- GHB-O-β-glucuronide in blood and urine is not a suitable tool for the extension of the detection window after GHB intake (2017) (19)
- Expanding sports drug testing assays: mass spectrometric characterization of the selective androgen receptor modulator drug candidates RAD140 and ACP-105. (2013) (19)
- Solutions Advertised as Erythropoiesis-stimulating Products were Found to Contain Undeclared Cobalt and Nickel Species (2016) (19)
- Exercise Diminishes Plasma Neurofilament Light Chain and Reroutes the Kynurenine Pathway in Multiple Sclerosis (2021) (19)
- Detection of recombinant growth hormone in human plasma by a 2‐D PAGE method (2008) (19)
- Recent improvements in sports drug testing concerning the initial testing for peptidic drugs (< 2 kDa) - sample preparation, mass spectrometric detection, and data review. (2018) (18)
- Simultaneous determination of insulin, DesB30 insulin, proinsulin, and C-peptide in human plasma samples by liquid chromatography coupled to high resolution mass spectrometry (2016) (18)
- Mass spectrometric studies on the in vivo metabolism and excretion of SIRT1 activating drugs in rat urine, dried blood spots, and plasma samples for doping control purposes. (2014) (18)
- Evaluation of the biological activity of a growth hormone (GH) mutant (R77C) and its impact on GH responsiveness and stature. (2007) (18)
- Mass spectrometric characterization of efaproxiral (RSR13) and its implementation into doping controls using liquid chromatography-atmospheric pressure ionization-tandem mass spectrometry. (2006) (18)
- Mass spectrometry of steroid glucuronide conjugates. II-Electron impact fragmentation of 3-keto-4-en- and 3-keto-5alpha-steroid-17-O-beta glucuronides and 5alpha-steroid-3alpha,17beta-diol 3- and 17-glucuronides. (2001) (18)
- Challenges in Modern Anti-Doping Analytical Science. (2017) (18)
- Testing for the erythropoiesis-stimulating agent Sotatercept/ACE-011 (ActRIIA-Fc) in serum by means of Western blotting and LC-HRMS. (2016) (18)
- Validation of serum IGF-I as a biomarker to monitor the bioactivity of exogenous growth hormone agonists and antagonists in rabbits (2014) (18)
- Unambiguous identification and characterization of a long-term human metabolite of dehydrochloromethyltestosterone. (2018) (18)
- Terbutaline sulfoconjugate: characterization and urinary excretion monitored by LC/ESI-MS/MS. (2009) (17)
- Annual banned-substance review-analytical approaches in human sports drug testing. (2019) (17)
- GH mutant (R77C) in a pedigree presenting with the delay of growth and pubertal development: structural analysis of the mutant and evaluation of the biological activity. (2007) (17)
- Effect of the location of hydrogen abstraction on the fragmentation of diuretics in negative electrospray ionization mass spectrometry (2003) (17)
- The prohormone 19-norandrostenedione displays selective androgen receptor modulator (SARM) like properties after subcutaneous administration. (2008) (17)
- Organ distribution of 4-MEC, MDPV, methoxetamine and α-PVP: comparison of QuEChERS and SPE (2018) (17)
- Annual banned-substance review-analytical approaches in human sports drug testing 2019/2020. (2020) (17)
- Investigation of the selective androgen receptor modulators S1, S4 and S22 and their metabolites in equine plasma using high-resolution mass spectrometry. (2016) (17)
- Identification of fibroblast growth factor 1 (FGF-1) in a black market product. (2011) (17)
- Recent advances in the determination of insulins from biological fluids. (2019) (17)
- Determination of Tuaminoheptane in Doping Control Urine Samples (2007) (17)
- Prevalence of antidepressants and biosimilars in elite sport. (2009) (17)
- Effects of exercise on the urinary proteome. (2015) (16)
- Immunoaffinity techniques coupled to mass spectrometry for the analysis of human peptide hormones: advances and applications (2017) (16)
- Potential of GHB phase-II-metabolites to complement current approaches in GHB post administration detection. (2017) (16)
- Urinary excretion of exogenous glycerol administration at rest. (2011) (16)
- Mass spectrometry-based analysis of IGF-1 and hGH. (2010) (16)
- Analysis of octopamine in human doping control samples. (2012) (16)
- Mass spectrometric studies on selective androgen receptor modulators (SARMs) using electron ionization and electrospray ionization/collision-induced dissociation (2018) (16)
- Gel electrophoretic methods for the analysis of biosimilar pharmaceuticals using the example of recombinant erythropoietin. (2013) (16)
- Development of a mass spectrometry based detection method for the mitochondrion-derived peptide MOTS-c in plasma samples for doping control purposes. (2019) (15)
- Mapping the interaction of cofilin with subdomain 2 on actin. (2007) (15)
- Seizures of doping substances at the Swiss Border--a descriptive investigation. (2015) (15)
- Screening for the calstabin-ryanodine receptor complex stabilizers JTV-519 and S-107 in doping control analysis. (2009) (15)
- Isolation, enrichment, and analysis of erythropoietins in anti-doping analysis by receptor-coated magnetic beads and liquid chromatography-mass spectrometry. (2014) (15)
- Annual banned-substance review: the Prohibited List 2008-analytical approaches in human sports drug testing. (2009) (15)
- Dried blood spots (DBS) in doping controls: a complementary matrix for improved in- and out-of-competition sports drug testing strategies (2015) (15)
- Complementing the characterization of in vivo generated N-glucuronic acid conjugates of stanozolol by collision cross section computation and analysis. (2015) (15)
- Revisiting the metabolism of 19-nortestosterone using isotope ratio and high resolution/high accuracy mass spectrometry (2016) (15)
- Mass spectrometric detection of peginesatide in human urine in doping control analysis. (2012) (15)
- lmplementation of the prolyl hydroxylase inhibitor Roxadustat (FG-4592) and its main metabolites into routine doping controls. (2017) (15)
- QUANTITATIVE DETERMINATION OF METABOLIC PRODUCTS OF 19-NORANDROSTENEDIOL IN HUMAN PLASMA USING GAS CHROMATOGRAPHY/MASS SPECTROMETRY (2006) (14)
- Equine in vivo-derived metabolites of the SARM LGD-4033 and comparison with human and fungal metabolites. (2018) (14)
- Identification and Quantification of the Osmodiuretic Mannitol in Urine for Sports Drug Testing Using Gas Chromatography-Mass Spectrometry (2008) (14)
- Structural elucidation of major selective androgen receptor modulator (SARM) metabolites for doping control. (2018) (14)
- Glycerol administration before endurance exercise: metabolism, urinary glycerol excretion and effects on doping-relevant blood parameters. (2014) (14)
- Methotrexate reduces HbA1c concentration but does not produce chronic accumulation of ZMP in patients with rheumatoid or psoriatic arthritis (2016) (14)
- Formation of the N-methylpyridinium derivative to improve the detection of buprenorphine by liquid chromatography-mass spectrometry. (2008) (14)
- Di(2-ethylhexyl) phthalate metabolites as markers for blood transfusion in doping control: intra-individual variability of urinary concentrations. (2011) (14)
- Mass spectrometric characterization of the selective androgen receptor modulator (SARM) YK-11 for doping control purposes. (2017) (14)
- Optimization of an online heart-cutting multidimensional gas chromatography clean-up step for isotopic ratio mass spectrometry and simultaneous quadrupole mass spectrometry measurements of endogenous anabolic steroid in urine. (2016) (14)
- Urine analysis concerning xenon for doping control purposes. (2015) (13)
- Development of two complementary LC-HRMS methods for analyzing sotatercept in dried blood spots for doping controls. (2019) (13)
- Detection of an unknown fusion protein in confiscated black market products. (2014) (13)
- Applications of Isotope Ratio Mass Spectrometry in Sports Drug Testing Accounting for Isotope Fractionation in Analysis of Biological Samples. (2017) (13)
- Studies on the in vivo metabolism of Methylstenbolone and detection of novel long term metabolites for doping control analysis. (2019) (13)
- Fragmentation studies of SIRT1-activating drugs and their detection in human plasma for doping control purposes. (2013) (13)
- Liquid Chromatography-High Resolution/High Accuracy (Tandem) Mass Spectrometry-Based Identification of in vivo Generated Metabolites of the Selective Androgen Receptor Modulator ACP-105 for Doping Control Purposes (2014) (13)
- In vitro Metabolism Studies on the Selective Androgen Receptor Modulator LG121071 and its Implementation into Human Doping Controls Using Liquid Chromatography-Mass Spectrometry (2015) (13)
- RNA interference for performance enhancement and detection in doping control. (2011) (13)
- Characterization of In Vitro Synthesized Equine Metabolites of the Selective Androgen Receptor Modulators S24 and S4 (2012) (13)
- Annual banned-substance review: Analytical approaches in human sports drug testing. (2019) (12)
- Single-dose administration of clenbuterol is detectable in Dried Blood Spots. (2020) (12)
- Doping control analysis of trimetazidine and characterization of major metabolites using mass spectrometric approaches. (2014) (12)
- Mass spectrometric characterization of a biotechnologically produced full-length mechano growth factor (MGF) relevant for doping controls. (2014) (12)
- The atypical excretion profile of meldonium: Comparison of urinary detection windows after single‐ and multiple‐dose application in healthy volunteers (2017) (12)
- Detection of small interfering RNA (siRNA) by mass spectrometry procedures in doping controls. (2013) (12)
- Antibody-based strategies for the detection of Luspatercept (ACE-536) in human serum. (2017) (12)
- Studies on the in vivo metabolism of the SARM YK11: Identification and characterization of metabolites potentially useful for doping controls. (2018) (12)
- Solid-phase extraction-liquid chromatography-tandem mass spectrometry method for the qualitative analysis of 61 synthetic cannabinoid metabolites in urine. (2019) (11)
- Combined detection of the ActRII-Fc fusion proteins Sotatercept (ActRIIA-Fc) and Luspatercept (modified ActRIIB-Fc) in serum by means of immunoaffinity purification, tryptic digestion, and LC-MS/MS. (2018) (11)
- Inter-Laboratory Agreement of Insulin-like Growth Factor 1 Concentrations Measured Intact by Mass Spectrometry. (2020) (11)
- Identification of Selected in vitro-Generated Phase-I Metabolites of the Steroidal Selective Androgen Receptor Modulator MK-0773 for Doping Control Purposes (2016) (11)
- Post-mortem distribution of the synthetic cannabinoid MDMB-CHMICA and its metabolites in a case of combined drug intoxication (2018) (11)
- Monitoring drug residues in donor blood/plasma samples using LC-(MS)/MS--a pilot study. (2013) (11)
- N-methyl-N-Trimethylsilyltrifluoroacetamide-Promoted Synthesis and Mass Spectrometric Characterization of Deuterated Ephedrines (2004) (11)
- Posttranslational hydroxylation of human phenylalanine hydroxylase is a novel example of enzyme self-repair within the second coordination sphere of catalytic iron. (2003) (11)
- Detection of the protease bacillolysin in doping-control urine samples. (2009) (11)
- Organ distribution of diclazepam, pyrazolam and 3-fluorophenmetrazine. (2019) (11)
- Investigation of the metabolites of the HIF stabilizer FG‐4592 (roxadustat) in five different in vitro models and in a human doping control sample using high resolution mass spectrometry (2017) (11)
- Development and validation of a multidimensional gas chromatography/combustion/isotope ratio mass spectrometry-based test method for analyzing urinary steroids in doping controls. (2018) (11)
- Paper spray mass spectrometry - A potential complementary technique for the detection of polar compounds in sports drug testing. (2020) (11)
- Monitoring phosphodiesterase-4 inhibitors using liquid chromatography/(tandem) mass spectrometry in sports drug testing. (2013) (10)
- Detection and pharmacokinetics of tetrahydrogestrinone in horses. (2009) (10)
- Analysis of new growth promoting black market products. (2018) (10)
- Identification and characterization of in vitro and in vivo generated metabolites of the adiponectin receptor agonists AdipoRon and 112254. (2016) (10)
- Analytical challenges in sports drug testing (2018) (10)
- Annual banned-substance review: analytical approaches in human sports drug testing. (2017) (10)
- Screening for benfluorex and its major urinary metabolites in routine doping controls (2011) (10)
- Mass spectrometric characterization of the hypoxia-inducible factor (HIF) stabilizer drug candidate BAY 85-3934 (molidustat) and its glucuronidated metabolite BAY-348, and their implementation into routine doping controls. (2017) (10)
- Meta-analysis: Effects of glycerol administration on plasma volume, haemoglobin, and haematocrit. (2013) (10)
- In vitro metabolic profiling of synthetic cannabinoids by pooled human liver microsomes, cytochrome P450 isoenzymes, and Cunninghamella elegans and their detection in urine samples (2019) (10)
- Detection of the Human Anti‐ActRII Antibody Bimagrumab in Serum by Means of Affinity Purification, Tryptic Digestion, and LC‐HRMS (2018) (10)
- SARCOSYL-PAGE: Optimized Protocols for the Separation and Immunological Detection of PEGylated Proteins. (2018) (10)
- Annual banned-substance review -analytical approaches in human sports drug testing 2020/2021. (2021) (10)
- Effects of 3 Weeks of Oral Low-Dose Cobalt on Hemoglobin Mass and Aerobic Performance (2018) (10)
- Mass spectrometric characterization of a prolyl hydroxylase inhibitor GSK1278863, its bishydroxylated metabolite, and its implementation into routine doping controls. (2016) (10)
- Carbon isotope ratio analysis of steroids by high-temperature liquid chromatography-isotope ratio mass spectrometry. (2014) (10)
- Organ-on-a-chip: Determine feasibility of a human liver microphysiological model to assess long-term steroid metabolites in sports drug testing. (2021) (10)
- Differing Water Intake and Hydration Status in Three European Countries—A Day-to-Day Analysis (2019) (10)
- Development and validation of a HPLC–QTOF-MS method for the determination of GHB-β-O-glucuronide and GHB-4-sulfate in plasma and urine (2016) (10)
- Detection of Sotatercept (ACE-011) in human serum by SAR-PAGE and western single blotting. (2018) (9)
- Drug Testing and Analysis' one‐year impact factor (2012) (9)
- Quantification of polyreactive immunoglobulin G facilitates the diagnosis of autoimmune hepatitis (2021) (9)
- Sports Drug Testing and the Athletes' Exposome. (2021) (9)
- Mass Spectrometry-Based Characterization of New Drugs and Methods of Performance Manipulation in Doping Control Analysis (2010) (9)
- Analysis of cobalt for human sports drug testing purposes using ICP- and LC-ICP-MS. (2020) (9)
- Screening and confirmation of myo-inositol trispyrophosphate (ITPP) in human urine by hydrophilic interaction liquid chromatography high resolution / high accuracy mass spectrometry for doping control purposes. (2014) (9)
- Comprar Mass Spectrometry In Sports Drug Testing: Characterization Of Prohibited Substances And Doping Control Analytical Assays | M. Thevis | 9780470413272 | Wiley (2010) (9)
- Detection of the myostatin-neutralizing antibody Domagrozumab in serum by means of Western blotting and LC-HRMS. (2019) (9)
- Growth hormone isoform-differential mass spectrometry for doping control purposes. (2018) (9)
- Acute hypertrophic but not maximal strength loading transiently enhances the kynurenine pathway towards kynurenic acid (2020) (9)
- Mitragynine (Kratom) - monitoring in sports drug testing. (2016) (9)
- Xenon elimination kinetics following brief exposure. (2017) (9)
- Elimination profiles of microdosed ostarine mimicking contaminated products ingestion. (2020) (9)
- Myostatin inhibitors in sports drug testing: Detection of myostatin‐neutralizing antibodies in plasma/serum by affinity purification and Western blotting (2016) (8)
- Phase I metabolic profiling of the synthetic cannabinoids THJ-018 and THJ-2201 in human urine in comparison to human liver microsome and cytochrome P450 isoenzyme incubation (2018) (8)
- Do dried blood spots (DBS) have the potential to support result management processes in routine sports drug testing? - Part 2: Proactive sampling for follow-up investigations concerning atypical or adverse analytical findings. (2021) (8)
- Anti-doping analysis (2011) (8)
- Synthesis, mass spectrometric characterization, and analysis of the PPARδ agonist GW1516 and its major human metabolites: targets in sports drug testing. (2013) (8)
- AOD-9604 does not influence the WADA hGH isoform immunoassay. (2013) (8)
- Electron ionization mass spectrometry of the ryanodine receptor-based Ca(2+)-channel stabilizer S-107 and its implementation into routine doping control. (2009) (8)
- Mass spectrometric characterization of glucuronides formed by a new concept, combining Cunninghamella elegans with TEMPO. (2013) (8)
- Mass spectrometric studies on the in vitro generated metabolites of SIRT1 activating drugs for doping control purposes. (2013) (8)
- Doping Control Analysis of Methoxyphenamine Using Liquid Chromatography-Tandem Mass Spectrometry (2008) (8)
- Characterization of in vitro generated metabolites of selected peptides <2 kDa prohibited in sports. (2017) (8)
- Preliminary data on the potential for unintentional anti-doping rule violations by permitted CBD use. (2020) (8)
- Analytical detection of trimetazidine produced by metabolic conversion of lomerizine in doping control analysis. (2016) (7)
- Current Insights into the Steroidal Module of the Athlete Biological Passport (2021) (7)
- Recent advances in identifying and utilizing metabolites of selected doping agents in human sports drug testing. (2021) (7)
- Mass spectrometry in sports drug testing (2014) (7)
- Effects of gamma irradiation and 15 days of subsequent ex vivo storage on the cytosolic red blood cell proteome analyzed by 2D‐DIGE and Orbitrap MS (2013) (7)
- Updated protocols for the detection of Sotatercept and Luspatercept in human serum. (2018) (7)
- Doping Control Analysis of Metamfepramone and Two Major Metabolites Using Liquid Chromatography-Tandem Mass Spectrometry (2009) (7)
- Does oral fluid contribute to exhaled breath samples collected by means of an electret membrane? (2019) (7)
- Elevated urinary cobalt concentrations identified in routine doping controls can originate from vitamin B12. (2019) (7)
- First use of the anti‐VWF nanobody caplacizumab to treat iTTP in pregnancy (2021) (7)
- Effect of Acute and Chronic Xenon Inhalation on Erythropoietin, Hematological Parameters, and Athletic Performance. (2019) (7)
- Mass spectrometric analysis of androstan-17beta-ol-3-one and androstadiene-17beta-ol-3-one isomers. (2005) (7)
- Analysis of Major Isoforms of Human Growth Hormone before and after Intensive Physical Exercise (2008) (7)
- Determination of LongR3-IGF-I, R3-IGF-I, Des1-3 IGF-I and their metabolites in human plasma samples by means of LC-MS. (2017) (7)
- EPOR-Based Purification and Analysis of Erythropoietin Mimetic Peptides from Human Urine by Cys-Specific Cleavage and LC/MS/MS (2015) (7)
- Implementation and performance of the gas chromatography/combustion/isotope ratio mass spectrometry-based method for the confirmatory analysis of endogenous anabolic steroids during the Rio de Janeiro Olympic and Paralympic Games 2016. (2019) (6)
- Case Study: Atypical δ13 C values of urinary norandrosterone. (2018) (6)
- Screening for adiponectin receptor agonists and their metabolites in urine and dried blood spots (2017) (6)
- Identification of metabolites of peptide-derived drugs using an isotope-labeled reporter ion screening strategy (2019) (6)
- Control of methylxanthines in the competition horse: pharmacokinetic/pharmacodynamic studies on caffeine, theobromine and theophylline for the assessment of irrelevant concentrations. (2017) (6)
- Probing for corticotropin-releasing hormone (CRH) in human blood for doping control purposes using immunoaffinity purification and LC-HRMS/MS (2017) (6)
- Fatalities associated with NPS stimulants in the Greater Cologne area (2019) (6)
- Micronucleus induction in V79 cells by the anabolic doping steroids desoxymethyltestosterone (madol) and 19-norandrostenedione. (2008) (6)
- Factitious administration of analogue insulin to a 2-year-old child (2015) (6)
- Analysis of taxine B/isotaxine B in a plasma specimen by LC–MS/MS in a case of fatal poisoning: concealed suicide by ingestion of yew (Taxus L.) leaves of a patient with a long-term history of borderline personality disorder (2017) (6)
- Stanozolol-N-glucuronide metabolites in human urine samples as suitable targets in terms of routine anti-doping analysis. (2021) (6)
- Identification of Trenbolone Metabolites Using Hydrogen Isotope Ratio Mass Spectrometry and Liquid Chromatography/High Accuracy/High Resolution Mass Spectrometry for Doping Control Analysis (2020) (6)
- Enzyme-assisted synthesis and structural characterization of pure benzodiazepine glucuronide epimers. (2010) (6)
- Is heptaminol a (major) metabolite of octodrine? (2019) (6)
- In vitro elucidation of the metabolic profile of the synthetic cannabinoid receptor agonists JWH-175 and JWH-176 (2016) (6)
- Nickel in equine sports drug testing - pilot study results on urinary nickel concentrations. (2016) (6)
- Monitoring 2-phenylethanamine and 2-(3-hydroxyphenyl)acetamide sulfate in doping controls. (2015) (6)
- Detection of Peginesatide in Equine Serum Using Liquid Chromatography-Tandem Mass Spectrometry for Doping Control Purposes (2012) (5)
- Identification and characterization of urinary prenylamine metabolites by means of liquid chromatography-tandem mass spectrometry. (2012) (5)
- Illicit organogenesis (2008) (5)
- Formation of the diuretic chlorazanil from the antimalarial drug proguanil--implications for sports drug testing. (2015) (5)
- Peptidic drugs and drug candidates in sports drug testing: agents affecting mitochondrial biogenesis or preventing activin receptor II activation (2019) (5)
- Mass Spectrometry and the List of Prohibited Substances and Methods of Doping (2010) (5)
- Potency of Full- Length MGF to Induce Maximal Activation of the IGF-I R Is Similar to Recombinant Human IGF-I at High Equimolar Concentrations (2016) (5)
- First Steps toward Uncovering Gene Doping with CRISPR/Cas by Identifying SpCas9 in Plasma via HPLC-HRMS/MS. (2020) (5)
- Facilitated Qualitative Determination of Insulin, Its Synthetic Analogs, and C-Peptide in Human Urine by Means of LC–HRMS (2021) (5)
- Probing for the presence of doping agents in exhaled breath using chromatographic-mass spectrometric approaches. (2020) (5)
- Tainted toothpaste - analytical investigation into an unusual adverse finding. (2020) (5)
- Detection of follistatin-based inhibitors of the TGF-β signaling pathways in serum/plasma by means of LC-HRMS/MS & Western blotting. (2020) (5)
- Effect of a Single Bout of Aerobic Exercise on Kynurenine Pathway Metabolites and Inflammatory Markers in Prostate Cancer Patients—A Pilot Randomized Controlled Trial (2020) (5)
- Safety, hemodynamic effects and detection of acute xenon inhalation: Rationale for banning xenon from sport. (2019) (5)
- Carbon isotope ratios of endogenous steroids found in human serum—method development, validation, and reference population-derived thresholds (2021) (5)
- Detecting the misuse of 7-oxo-DHEA by means of carbon isotope ratio mass spectrometry in doping control analysis. (2020) (5)
- Isotope-dilution mass spectrometric quantification of the prodrug lisdexamfetamine in human urine in doping control analysis. (2014) (4)
- Studies on the collision-induced dissociation of adipoR agonists after electrospray ionization and their implementation in sports drug testing. (2015) (4)
- Analysis of Low Molecular Weight Substances in Doping Control (2008) (4)
- Investigations into the elimination profiles and metabolite ratios of micro-dosed selective androgen receptor modulator LGD-4033 for doping control purposes (2021) (4)
- The Role of Mass Spectrometry for Peptide, Protein, and Proteome Characterization (2012) (4)
- [Doping in disabled sports. Doping control activities at the Paralympic Games 1984-2008 and in Germany 1992-2008]. (2009) (4)
- Implementation of the HIF activator IOX-2 in routine doping controls - pilot study data. (2020) (4)
- RECENT ADVANCES IN DOPING ANALYSES (2) (2007) (4)
- Isolation and characterization of a β-glucuronide of hydroxylated SARM S1 produced using a combination of biotransformation and chemical oxidation. (2014) (4)
- An in vitro assay approach to investigate the potential impact of different doping agents on the steroid profile. (2020) (4)
- Annual banned-substance review: analytical approaches in human sports drug testing. (2014) (4)
- In vitro synthesis and characterisation of three fenoterol sulfoconjugates detected in fenoterol post-administration urine samples (2013) (4)
- Performance‐Enhancing Drugs (2009) (3)
- Meldonium residues in milk: A possible scenario for inadvertent doping in sports? (2021) (3)
- Pharmacokinetics and pharmacodynamics of meldonium in exercised thoroughbred horses. (2017) (3)
- Influence of repeated subcutaneous G-CSF injections on selected blood parameters relevant for monitoring programmes in sports drug testing. (2012) (3)
- Wiley‐Interscience Series in Mass Spectrometry (2010) (3)
- Metabolism of “ new ” anabolic steroids : Development of in vitro methodology in metabolite production and analytical techniques (2007) (3)
- Data from a microdosed recombinant human erythropoietin administration study applying the new biotinylated clone AE7A5 antibody and a further optimized sarcosyl polyacrylamide gel electrophoresis protocol (2021) (3)
- Probing for the presence of semenogelin in human urine by immunological and chromatographic‐mass spectrometric methods in the context of sports drug testing (2021) (3)
- Determination of ghrelin and desacyl ghrelin in human plasma and urine by means of LC-MS/MS for doping controls. (2021) (3)
- Annual banned-substance review: analytical approaches in human sports drug testing. (2015) (3)
- Urinary Excretion Of Exogenous Glycerol Administered Before Endurance Exercise: 2982 (2011) (3)
- Detection of Black Market Follistatin 344. (2019) (3)
- Effects of different exercise intensities in the morning on football performance components in the afternoon (2018) (3)
- Identification of proteolytic enzymes in human urine (2008) (3)
- Detection of anti‐SARS‐CoV‐2 antibodies in dried blood spots utilizing manual or automated spot extraction and electrochemiluminescence immunoassay (ECLIA) (2021) (3)
- Modern Mass Spectrometry‐Based Analytical Assays (2010) (3)
- Analysis of endogenous steroids in urine by means of multi-immunoaffinity chromatography and isotope ratio mass spectrometry for sports drug testing (2019) (3)
- Novel CB1-ligands maintain homeostasis of the endocannabinoid system in ω3- and ω6-long-chain-PUFA deficiency[S] (2019) (3)
- Application of the Athlete Biological Passport approach to the detection of growth hormone doping. (2021) (3)
- Comparison of hGH serum concentrations of Caucasian and African top athletes : an ethnicity study (2011) (2)
- Effect of changes in the deuterium content of drinking water on the hydrogen isotope ratio of urinary steroids in the context of sports drug testing (2013) (2)
- Annual banned-substance review: analytical approaches in human sports drug testing. (2010) (2)
- Mass spectrometric identification and characterization of a new long-term metabolite of metandienone (2006) (2)
- Carbon isotope ratios of endogenous steroids in Belgian Blue and Holstein cattle: Method development, reference population studies and application to steroid misuse control. (2017) (2)
- Chromatographic-mass spectrometric analysis of the urinary metabolite profile of chlorphenesin observed after dermal application of chlorphenesin-containing sunscreen. (2021) (2)
- Detection of undeclared doping substances in nutritional supplements in the context of follow-up investigations concerning adverse analytical findings. (2021) (2)
- New Sample Preparation Procedure for the Confirmation of Stanozolol and its Metabolites by Means of GC / MSMS and LC / ESI-MSMS (2007) (2)
- Stereoisomers in sports drug testing: Analytical strategies and applications. (2022) (2)
- Effects of insulin and analogues on carcinogen-induced mammary tumours in high-fat-fed rats (2018) (2)
- Mass spectrometric characterization of urinary hydrafinil metabolites for routine doping control purposes. (2021) (2)
- Investigation of Equine In Vivo and In Vitro Derived Metabolites of the Selective Androgen Receptor Modulator (SARM) ACP-105 for Improved Doping Control (2021) (2)
- Testosterone: Detection of illegal use of androgens and selective androgen receptor modulators (2012) (2)
- Organic Chemistry of Drug Degradation. Authored by Min Li (2013) (2)
- Response to Letter to the Editor regarding “Rapid determination of urinary di(2-ethylhexyl) phthalate metabolites based on liquid chromatography/tandem mass spectrometry as a marker for blood transfusion in sports drug testing” (2011) (2)
- Phase I-metabolism studies of the synthetic cannabinoids PX-1 and PX-2 using three different in vitro models (2021) (2)
- Analytik modifizierter Steroidhormone mittels Flüssigkeitschromatographie/Tandem-Massenspektrometrie Analysis of modified steroid hormones using liquid chromatography/tandem mass spectrometry (2006) (2)
- Measurement of exogenous gamma-hydroxybutyric acid ( GHB ) in urine using isotope ratio mass spectrometry ( IRMS ) (2015) (2)
- Broadening the Horizon of Antidoping Analytical Approaches Using Dried Blood Spots. (2021) (2)
- Pilot study on the effects of intravesical oxybutynin hydrochloride instillations on the validity of doping control urine samples. (2019) (2)
- Toxicology of Specific Substances (2014) (2)
- DropWise: current role and future perspectives of dried blood spots (DBS), blood microsampling, and their analysis in sports drug testing (2022) (2)
- Structure Characterization of High Molecular Weight Target Analytes: Electrospray Ionization (2010) (1)
- Kinetic disposition of diazepam and its metabolites after intravenous administration of diazepam in the horse: Relevance for doping control. (2021) (1)
- Probing for factors influencing exhaled breath drug testing in sports - pilot studies focusing on the tested individual's tobacco smoking habit and sex. (2022) (1)
- Correction to: Post-mortem distribution of the synthetic cannabinoid MDMB-CHMICA and its metabolites in a case of combined drug intoxication (2018) (1)
- Identification and monitoring of octopamine sulfoconjugate in urine by LC / ( ESI )-MS / MS (2012) (1)
- Annual banned-substance review -analytical approaches in human sports drug testing 2021/2022. (2022) (1)
- Growth hormone: barriers to the implementation of human growth hormone testing in sport. Interview by Paul Trevorrow. (2009) (1)
- Analytics of nonpeptidic erythropoietin mimetic agents in sports drug testing employing high-resolution/high-accuracy liquid chromatography-mass spectrometry (2016) (1)
- In vivo metabolism of Selective Androgen Receptor Modulators (SARMs) in the horse (2014) (1)
- Using electrochemistry for metabolite simulation and synthesis in preventive doping research: application to the Rycal S107 and the PPARδ-agonist GW1516 (2013) (1)
- In reply (2012) (1)
- Assessing human urinary clomiphene metabolites after consumption of eggs from clomiphene-treated laying hens using chromatographic-mass spectrometric approaches. (2022) (1)
- Excretion of 19-norandrosterone after consumption of boar meat. (2020) (1)
- The 33rd Manfred Donike Workshop on Doping Analysis. (2015) (1)
- Comprehensive insights into the formation of metabolites of the ghrelin mimetics capromorelin, macimorelin and tabimorelin as potential markers for doping control purposes. (2021) (1)
- OR07-3 Measurement of serum IGF-1 by LC-MS-MS: A multi-site validation study for anti-doping testing (2012) (1)
- Synthesis of Four SIRT1 Activators Based on an Imidazo(1,2-b)thiazole Structure, in vitro Derived Metabolites and Deuterated Analogs (2014) (1)
- The 36th Manfred Donike workshop on doping analysis. (2018) (1)
- Detection of black market follistatin 344. (2020) (1)
- Mass spectrometric study of the metabolism of Selective Androgen Receptor Modulators (SARMs) in the fungus Cunninghamella elegans (2012) (1)
- Data from a microdosed rhEPO administration study applying the new biotinylated clone AE7A5 antibody and a further optimized SAR-PAGE protocol. (2021) (1)
- Androgens, sports, and detection strategies for anabolic drug use. (2021) (1)
- Depletion of clomiphene residues in eggs and muscle after oral administration to laying hens (2021) (1)
- History of Sports Drug Testing (2010) (1)
- Could Nickel Become a Novel Erythropoiesis-Stimulating Compound for Cheating Athletes? (2016) (1)
- Investigation about the effects and the detection of finasteride, a substance which can be misused as masking agent in doping control (2006) (1)
- Determination and enantioselective separation of zilpaterol in human urine after mimicking consumption of contaminated meat by HPLC-MS/MS techniques. (2022) (1)
- Screening for Anastrozole in Doping Analysis (2006) (1)
- Sensitive detection of testosterone and testosterone prohormone administrations based on urinary concentrations and carbon isotope ratios of androsterone and etiocholanolone. (2021) (1)
- Chiral analysis of selected enantiomeric drugs relevant in doping controls (2021) (1)
- Evaluation of AMGEN clone 9G8A anti-Epo antibody for application in doping control. (2016) (1)
- Impact of recent biochemical findings on the determination of free and bioavailable testosterone: evaluation and proposal for clinical use / Auswirkungen neuer biochemischer Befunde auf die Bestimmung von freiem und bioverfügbarem Testosteron: Evaluierung und Vorschlag für den klinischen Einsatz (2006) (1)
- Investigations in carbon isotope ratios of seized testosterone and boldenone preparations. (2021) (1)
- Analysis of dried blood spots is a feasible alternative for detecting ephedrine in doping control. (2022) (1)
- Risk of unintentional antidoping rule violations by consumption of hemp products. (2022) (1)
- The 35th Manfred Donike workshop on doping analysis. (2017) (1)
- Guest Editorial (2008) (0)
- Enzyme-assisted synthesis and characterization of benzodiazepine glucuro-nides (2008) (0)
- Hypoxia-inducible factor ( HIF ) pathway as target for doping purposes and mass spectrometric characterisation of orally available model HIF-stabilizers (2010) (0)
- Effects of different exercise intensities in the morning on football performance components in the afternoon (2018) (0)
- Detectability of oxandrolone, metandienone, clostebol and dehydrochloromethyltestosterone in urine after transdermal application. (2022) (0)
- The human mitochondrial cytochromes P450 CYP11A1, CYP11B1 and CYP11B2 are involved in the biosynthesis of steroid hormones. CYP11A1 catalyzes the side-chain cleavage of cholesterol and CYP11B1 and CYP11B2 catalyze the final steps in the biosynthesis of gluco- (2015) (0)
- Long-acting octreotide (Sandostatin LAR®) causes marked and sustained decrease in total and acyl ghrelin concentrations in adolescents with Prader-Willi Syndrome (2007) (0)
- Counter-regulatory responses to postprandial hypoglycaemia in patients with post-bariatric hypoglycaemia vs surgical and non-surgical control individuals (2023) (0)
- Gender Differences In COPD And New Potential Biomarkers For Diagnosis By Proteomics Analysis (2012) (0)
- Usefulness of serum androgen isotope ratio mass spectrometry (IRMS) to detect testosterone supplementation in women. (2022) (0)
- A Targeted Liquid Chromatography-Tandem Mass Spectrometry Method for Simultaneous Quantification of Peptides from the Carboxyl-terminal Region of Type III Procollagen, Biomarkers of Collagen Turnover. (2022) (0)
- Qualitative determination of synthetic insulin analogues in human plasma by means of LC-MS / MS (2006) (0)
- 19-NORANDROSTENEDIOL IN HUMAN PLASMA USING GAS QUANTITATIVE DETERMINATION OF METABOLIC PRODUCTS OF (2015) (0)
- Response to letter to the editor: "Comments on Unambiguous identification and characterization of a long-term human metabolite of dehydrochloromethyltestosterone". (2018) (0)
- Contents: Proteomics 2'16. (2016) (0)
- [Doping control activities in Germany 1989-2006]. (2008) (0)
- The 39th Manfred Donike workshop on doping analysis. (2021) (0)
- Qualitative determination of rapid acting insulin analogues in urine by means of LC-MS / MS (2007) (0)
- Mass spectrometry in sports drug testing-Analytical approaches and the athletes' exposome. (2022) (0)
- Limitations and Perspectives of Mass Spectrometry‐Based Procedures in Doping Control Analysis (2010) (0)
- ELEVATION OF SERUM CARTILAGE OLIGOMERIC MATRIX PROTEIN (COMP) LEVEL DEPENDS ON LOADING MODE OF PHYSICAL ACTIVITY – PRELIMINARY RESULTS (2008) (0)
- Identification of black market products and potential doping agents in Germany 2010–2013 (2014) (0)
- Human In Vivo Metabolism and Elimination Behavior of Micro-Dosed Selective Androgen Receptor Modulator RAD140 for Doping Control Purposes (2022) (0)
- Investigations on storage-induced changes of the red blood cell lipidome (2014) (0)
- Hugh L.J. Makin, David B. Gower (Eds.): Steroid analysis, 2nd ed. (2011) (0)
- Mass spectrometry in drug metabolism and pharmacokineticx Ragu Ramanathan, Editor (2009) (0)
- The 38th Manfred Donike workshop on doping analysis. (2020) (0)
- Increased Normalcy Rate with Computed Tomography Attenuation Correction in Single Positron Emission Computed Tomography Myocardial Perfusion Imaging – Is it Useful ? (2016) (0)
- SAT0219 Methotrexate-Induced Reduction in Concentration of HBA1C in Rheumatoid and Psoriatic Arthritis is Not Correlated with Sustained Increase in Erythrocyte ZMP or Urinary Aicar Concentration (2015) (0)
- Investigations into the In Vitro Metabolism of hGH and IGF-I Employing Stable-Isotope-Labelled Drugs and Monitoring Diagnostic Immonium Ions by High-Resolution/High-Accuracy Mass Spectrometry (2022) (0)
- Identification and determination of degradation products of human insulin and its long acting synthetic analogues in urine by means of ESI-LC-MS / MS (2008) (0)
- Relative mobility values for the discrimination of endogenous and recombinant EPO on SDS gels (2009) (0)
- Investigations on the in vivo metabolism of 5α-androst-2-en-17-one. (2022) (0)
- Detection of proteases and their proteolysis and autolysis products in urine by LC-MS (2010) (0)
- Direct Quantification of Salbutamol in Human Urine by Means of LC-MS / MS (2008) (0)
- Characterization of a Selective Androgen Receptor Modulator Drug Candidate and Identification of In Vitro Generated Metabolites for Sports Drug Testing (2015) (0)
- Quantification of 25-hydroxyvitamin D2 and D3 in Mitra® devices with volumetric absorptive microsampling technology (VAMS®) by UHPLC-HRMS for regular vitamin D status monitoring. (2023) (0)
- How to detect CRISPR with CRISPR - employing SHERLOCK for doping control purposes. (2022) (0)
- Drug glucuronides synthesized using a new concept combining Cunninghamella elegans with TEMPO (2013) (0)
- Detection and method validation of peginesatide in human serum by means of LC-MS/MS (2013) (0)
- Turning drug glucosides into glucuronides - making fungal incubations work together with chemical derivatization (2013) (0)
- Myostatin inhibitory peptides in sports drug testing. (2023) (0)
- GC-MS-IRMS : Undisputable results by coupling of GC-IRMS with high-resolution mass spectrometry for final confirmation in sports drug testing APPLICATION NOTE 30405 (2017) (0)
- Analysis of selective androgen receptor modulators by gas chromatography-microchip atmospheric pressure ionization-mass spectrometry (2008) (0)
- The 37th Manfred Donike Workshop on Doping Analysis. (2019) (0)
- Sport doping detection in focus: A perspective from Prof. Dr Mario Thevis (2020) (0)
- The 40th Manfred Donike workshop on doping analysis. (2022) (0)
- Safety, Detection and Hemodynamic Effects of Acute Xenon Inhalation: Implications for Athletic Doping Practices (2017) (0)
- In-vitro metabolis m selective androgen receptor modulators. [Conference poster]. (2012) (0)
- Glycerol as prohibited substance: meta-analysis on the effects of glycerol administration on haemoglobin, haematocrit and plasma volume (2013) (0)
- The 34th Manfred Donike Workshop on Doping Analysis. (2016) (0)
- Electrophoretic Detection of Black Market Myostatin Propeptide. (2022) (0)
- Hormone abuse in sports: the knowns and unknowns (2012) (0)
- Detection of dehydroepiandrosterone misusey means of gas chromatography-comustion-isotope ratio mass spectrometry (2007) (0)
- Acute hypertrophic but not maximal strength loading transiently enhances the kynurenine pathway towards kynurenic acid (2020) (0)
- V 01 In vitro THC degradation by the skin colonising yeast Malassezia furfur (2017) (0)
- Special issue-murders by drugs. (2009) (0)
- AICAr to SAICAr ratio can serve as additional marker of AICAr use. (2022) (0)
- Analysis of New Chemical Entities in a Sport Context (2021) (0)
- Several possible toxicological and genetic tools for the extension of the detection window after GHB intake (2017) (0)
- Mass spectrometric identification of human pituitary growth hormone variants (2008) (0)
- XIX. GTFCh-Symposium Vorträge V01 An albumin adduct with the chemical warfare agent sulfur mustard detected by LC-ESI MS/MS: a novel method for verification of poisoning (2015) (0)
- Addressing recent challenges in isotope ratio mass spectrometry: Development of a method applicable to 1-androstene-steroids, 6α-hydroxy-androstenedione and androstatrienedione. (2022) (0)
- Mass Spectrometry in Sports Drug Testing : Detection of New Anabolic and Endurance Enhancing Agents (2009) (0)
- Development of mass spectrometry-based methods for the detection of 11-ketotestosterone and 11-ketodihydrotestosterone. (2023) (0)
- Structure Characterization of Low Molecular Weight Target Analytes—Electron Ionization (2010) (0)
- In-vitro metabolism of GW1516 and implementation of its major metabolites in routine doping controls (2011) (0)
- Urinary phenylethylamine metabolites as potential markers for sports drug testing purposes. (2021) (0)
- Validation of a GC / MS method for the detection of two quinolinone-derived selective androgen receptor modulators in doping control analysis (2010) (0)
- Mass spectrometric identification and characterization of urinary metabolites of isopropylnorsynephrine for doping control purposes (2021) (0)
- 159-OR: Endocrine and Metabolic Counterregulation to Standardized Postprandial Hypoglycemia after Bariatric Surgery (2022) (0)
- Dried Blood Spots for Doping Controls - Development of a comprehensive Initial Testing Procedure with fully automated sample preparation. (2023) (0)
- Dried blood spots as option to monitor the anti-sars-cov-2 antibody response after infection or vaccination (2022) (0)
- Control of a Sulfadoxine/Trimethoprim Combination in the competition horse: Elimination, Metabolism and Detection following an intravenous Administration. (2023) (0)
- Metabolism of oral turinabol by the human brain cholesterol 24-hydroxylase CYP46A1 (2021) (0)
- Preliminary results for the development of a peptide screening method by means of LC-MS / MS (2011) (0)
- Probing for peptidic drugs (2–10 kDa) in doping control blood samples (2022) (0)
- Quantification of SARMs S1, S4 and S22 and detection of their metabolites in equine plasma usning UHPLC-Q-TOF (2015) (0)
- Do dried blood spots have the potential to support result management processes in routine sports drug testing?-Part 3: LC-MS/MS-based peptide analysis for dried blood spot sampling time point estimation. (2023) (0)
- Investigations into the concentration and metabolite profiles of stanozolol and LGD-4033 in blood plasma and seminal fluid using liquid chromatography high-resolution mass spectrometry (2022) (0)
- [Doping in sport]. (2007) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Mario Thevis?
Mario Thevis is affiliated with the following schools: